Table 5 Multivariate logistic regression model for predicting recovery from ISSNHL.
Independent variable | Adjusted OR | 95% CI | p-value |
|---|---|---|---|
Age | |||
< 60 | 1 | (Reference) | |
≥ 60 | 1.32 | 0.92 to 1.88 | 0.13 |
DM | 0.83 | 0.53 to 1.29 | 0.41 |
HTN | 0.60 | 0.41 to 0.87 | < 0.01** |
HLD | 0.83 | 0.56 to 1.24 | 0.37 |
V/D | 2.54 | 1.72 to 3.75 | < 0.01*** |
Initial MHLWa Grade of hearing loss, affected ear | |||
1–3 | 1 | (Reference) | |
4 | 3.42 | 1.84 to 6.35 | < 0.01*** |
Initial Grade of hearing loss, healthy ear | |||
0–1 | 1 | (Reference) | |
2–4 | 1.89 | 1.09 to 3.29 | 0.02* |
Hearing loss | |||
Low frequencies | 1.35 | 0.84 to 2.19 | 0.22 |
Middle frequencies | 1.53 | 0.76 to 3.09 | 0.23 |
High frequencies | 1.86 | 1.13 to 3.06 | 0.01* |
Regular anticoagulant medication at onset of hearing loss | 3.37 | 1.17 to 9.73 | 0.02* |
Received systemic steroid therapy, yes | 1.24 | 0.56 to 2.74 | 0.60 |
Received intratympanic steroid therapy (initial or salvage), yes | 0.70 | 0.34 to 1.41 | 0.32 |
Latency to begin steroid treatmentc | |||
0–7 days post-onset | 1 | (Reference) | |
8 or more days post-onset | 2.85 | 1.77 to 4.59 | < 0.01*** |
Received prostaglandin E1 treatment, yes | 0.83 | 0.54 to 1.27 | 0.38 |